| |
< 12 yrs |
≥ 12 yrs |
| Inpatient |
- Sequential compression device, if size allows
- Enoxaparin generally not indicated
- Discuss with hematology if multiple risk factors for VTE in addition to COVID-19
|
- Sequential compression devices, if size allows:
- and
- Enoxaparin
- 0.5 mg/kg/dose subQ q12hr
- Max initial dose: 60 mg subQ q12hr
- Goal anti-Xa: 0.2–0.4 units/mL
|
| ICU |
- No Mechanical ventilation or central venous catheter:
- Sequential compression devices
|
- Mechanical ventilation or central venous catheter:
- Sequential compression devices, if size allows
- and
- Enoxaparin
- < 3 mos: 0.75 mg/kg/dose subQ q12hr
- ≥ 3 mos: 0.5 mg/kg/dose subQ q12hr
Max initial dose: 60 mg subQ q12hr
- Goal anti-Xa: 0.2– 0.4 units/mL
|